glp 1 and keto GLP-1 Shot GLP-1 receptor agonists causing euglycemic
Description
First-time AOM semaglutide prescribing increased by over 50%, marking the largest quarter-over-quarter increase in first-time AOM semaglutide prescribing since mid-2024, likely driven by the approval of the oral formulation of Wegovy in December 2025

And this will challenge companies to adapt and innovate

"If someone were having this, what I would suggest is having a salad on the side or some extra vegetables on the side or incorporating some beans," she says

A 2025 study on liraglutide nanoparticles demonstrated successful transdermal delivery with sustained effects in early-stage testing

The two compounds operate through largely separate biological pathwaysGLP-1 receptors versus AMPK activationwhich is why researchers have theorized potential synergistic benefit
This study was published in the Endocrine Journal in 2021
